Brings et al., 2017 - Google Patents
Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for interventionBrings et al., 2017
View HTML- Document ID
- 3475072935055376094
- Author
- Brings S
- Fleming T
- Freichel M
- Muckenthaler M
- Herzig S
- Nawroth P
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
Advanced glycation end-products (AGEs) are non-enzymatic protein and amino acid adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is enhanced in diabetes and is associated with the development of diabetic complications. In …
- 108010005094 Advanced Glycation End Products 0 title abstract description 89
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/573—Immunoassay; Biospecific binding assay for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brings et al. | Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention | |
| Lee et al. | Amino acid metabolites associated with chronic kidney disease: an eight-year follow-up Korean epidemiology study | |
| Reddy | Oxidative stress in health and disease | |
| Tejchman et al. | Biomarkers and mechanisms of oxidative stress—last 20 years of research with an emphasis on kidney damage and renal transplantation | |
| Carrizzo et al. | The main determinants of diabetes mellitus vascular complications: endothelial dysfunction and platelet hyperaggregation | |
| Fratta Pasini et al. | Is ferroptosis a key component of the process leading to multiorgan damage in COVID-19? | |
| Santos et al. | Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products | |
| Elbarbry et al. | The antihypertensive effect of quercetin in young spontaneously hypertensive rats; role of arachidonic acid metabolism | |
| Ramírez Ortega et al. | On the antioxidant properties of L-kynurenine: An efficient ROS scavenger and enhancer of rat brain antioxidant defense | |
| Sadi et al. | Modulation of renal insulin signaling pathway and antioxidant enzymes with streptozotocin-induced diabetes: effects of resveratrol | |
| Saenz-Medina et al. | Endothelial dysfunction: an intermediate clinical feature between urolithiasis and cardiovascular diseases | |
| Đurašević et al. | The effects of meldonium on the renal acute ischemia/reperfusion injury in rats | |
| Milosevic et al. | Agmatine mitigates inflammation-related oxidative stress in BV-2 cells by inducing a pre-adaptive response | |
| Stratmann | Dicarbonyl stress in diabetic vascular disease | |
| Żebrowska et al. | High-sugar diet disrupts hypothalamic but not cerebral cortex redox homeostasis | |
| Stacchiotti et al. | Melatonin efficacy in obese leptin-deficient mice heart | |
| Chien et al. | Diabetes upregulates oxidative stress and downregulates cardiac protection to exacerbate myocardial ischemia/reperfusion injury in rats | |
| Blanco Ayala et al. | Subchronic N-acetylcysteine treatment decreases brain kynurenic acid levels and improves cognitive performance in mice | |
| Khan et al. | Glycation and oxidative stress increase autoantibodies in the elderly | |
| Čižmárová et al. | Salivary redox homeostasis in human health and disease | |
| Lee et al. | Antioxidant effect of barley sprout extract via enhancement of nuclear factor-erythroid 2 related factor 2 activity and glutathione synthesis | |
| Hosohata et al. | Involvement of vanin-1 in ameliorating effect of oxidative renal tubular injury in Dahl-salt sensitive rats | |
| Kalapos et al. | Metabolic shades of SD-Lactoylglutathione | |
| Wang et al. | Conditions conducive to the glutathionylation of complex I subunit NDUFS1 augment ROS production following the oxidation of ubiquinone linked substrates, glycerol-3-phosphate and proline | |
| Esimbekova et al. | Alternative enzyme inhibition assay for safety evaluation of food preservatives |